ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 72 filers reported holding ATHIRA PHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,690,501 | -31.5% | 4,797,278 | 0.0% | 0.32% | -21.2% |
Q2 2023 | $14,151,970 | +18.0% | 4,797,278 | 0.0% | 0.41% | +15.8% |
Q1 2023 | $11,993,195 | -21.1% | 4,797,278 | 0.0% | 0.35% | -17.1% |
Q4 2022 | $15,207,371 | +6.7% | 4,797,278 | 0.0% | 0.43% | +3.1% |
Q3 2022 | $14,248,000 | -2.6% | 4,797,278 | 0.0% | 0.41% | -9.6% |
Q2 2022 | $14,632,000 | -68.4% | 4,797,278 | +40.0% | 0.46% | -50.5% |
Q1 2022 | $46,250,000 | -48.2% | 3,425,916 | -50.0% | 0.93% | +34.4% |
Q4 2021 | $89,280,000 | +177.8% | 6,851,832 | +100.0% | 0.69% | +47.5% |
Q3 2021 | $32,135,000 | -54.2% | 3,425,916 | -50.0% | 0.47% | +2.4% |
Q2 2021 | $70,162,000 | +11.3% | 6,851,832 | +100.0% | 0.46% | -42.8% |
Q1 2021 | $63,037,000 | -40.9% | 3,425,916 | +10.0% | 0.80% | -30.4% |
Q4 2020 | $106,682,000 | +85.5% | 3,114,805 | 0.0% | 1.14% | +36.5% |
Q3 2020 | $57,499,000 | – | 3,114,805 | – | 0.84% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BML Capital Management, LLC | 1,704,362 | $3,442,811 | 3.16% |
Simplify Asset Management Inc. | 1,492,792 | $3,015,440 | 0.34% |
Perceptive Advisors | 4,797,278 | $9,690,501 | 0.32% |
Nan Fung Group Holdings Ltd | 180,000 | $363,600 | 0.29% |
Potomac Capital Management, Inc. | 74,585 | $150,662 | 0.19% |
Acuitas Investments, LLC | 149,600 | $302,192 | 0.18% |
TANG CAPITAL MANAGEMENT LLC | 352,715 | $712,484 | 0.10% |
GSA CAPITAL PARTNERS LLP | 297,052 | $600 | 0.05% |
Integrity Financial Corp /WA | 32,786 | $66,228 | 0.05% |
Laird Norton Wetherby Trust Company, LLC | 178,709 | $360,992 | 0.05% |